Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA

Date : 04/28/2009 @ 10:33AM
Source : PR Newswire
Stock : Hemispherx Biopharma, (HEB)
Quote : 0.71  -0.0251 (-3.41%) @ 7:59PM
<< BackQuote Chart Financials

 

Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA

DALLAS, April 28 /PRNewswire/ --

BeaconEquity.com announces the availability of Stock Alerts on stocks making news today. As the influenza dominates the headlines, several biopharmaceutical stocks are parading up the charts.

So how does swine flu affect the markets? Check out a video chart for three stocks (BCRX, AVII, DVAX) reeling from influenza news that should be on your radar this week at stockhideout.com.

Today's Stock Alerts include: Hemispherx Biopharma Inc. (AMEX:HEB), Generex Biotechnology Corp. (NASDAQ:GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Dynavax Technologies Corp. (NASDAQ:DVAX), Novavax Inc. (NASDAQ:NVAX) and Sinovac Biotech Ltd. (AMEX:SVA).

Investors can view all of the daily stock alerts for free by visiting BeaconEquity.com/m.

See what Cramer has to say about these stocks and many more.

BeaconEquity.com's Stock Alerts are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small-cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.

We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas.

BeaconEquity.com is one of the industry's largest small-cap research providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit:

http://www.beaconequity.com/m CRD# 2207572

BeaconEquity.com Disclosure

BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, BeaconEquity.com, for complete risks and disclosures.

David C. Masson of Beacon Equity Research is a member of the National Association of Securities Dealers, CRD number 2207572.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

JEFF BISHOP

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781

Beacon Equity Research

Jeff Bishop, (469)-252-3505

DATASOURCE: BeaconEquity.com

CONTACT: Jeff Bishop of Beacon Equity Research, +1-469-252-3505,

Web Site: http://www.beaconequityresearch.com/


Hemispherx Biopharma, Historical Chart Hemispherx Biopharma, Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
The Spread Bet Centre :: The CFD Centre :: Financial Glossary :: Forex Rates, Charts & News
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright 1999-2010 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
34 site:2us 100320 23:33